Journal Mobile Options
Table of Contents
Vol. 45, No. 2, 2012
Issue release date: February 2012
Psychopathology 2012;45:126–129
(DOI:10.1159/000329739)

Concurrent Koro and Cotard Syndromes in a Spanish Male Patient with a Psychotic Depression and Cerebrovascular Disease

Alvarez P. · Puente V.M. · Blasco M.J. · Salgado P. · Merino A. · Bulbena A.
To view the fulltext, log in and/or choose pay-per-view option

Individual Users: Register with Karger Login Information

Please create your User ID & Password





Contact Information











I have read the Karger Terms and Conditions and agree.

To view the fulltext, please log in

To view the pdf, please log in

Abstract

Koro and Cotard syndromes are uncommon conditions described in a variety of psychiatric and medical disorders. The authors report the third case of a simultaneous presentation of both syndromes, in a 62-year-old inpatient Spanish male with major depressive disorder with psychotic features, parkinsonism and cognitive impairment. A discussion of the literature and the possible relationship between both syndromes and other neuropsychiatric disorders are presented.



Copyright / Drug Dosage

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

References

  1. Berrios GE, Morley SJ: Koro like symptoms in a non-Chinese subject. Br J Psychiatry 1984;145:331–334.
  2. Anderson DN: Koro: the genital retraction symptom after stroke. Br J Psychiatry 1990;157:142–144.
  3. Chen E: Drug-induced Koro in a non-Chinese man. Br J Psychiatry 1991;158:721.
  4. Caballero JM, Avila A, Cardona X, Sastre F, Maho P, Bello J: Genital pain without urogenital pathology: the Koro-like syndrome. J Urol 2000;163:243.
  5. Ramírez-Bermúdez J, Aguilar-Venegas LC, Crail-Meléndez D, Espinola-Nadurille M, Nente F, Méndez MF: Cotard syndrome in neurological and psychiatric patients. J Neuropsychiatry Clin Neurosci 2010;22:409–416.
  6. Berrios GE, Luque R: Cotard’s delusion or syndrome? A conceptual history. Compr Psychiatry 1995;36:218–223.
  7. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, ed 4. Washington, American Psychiatric Association, 1994.
  8. World Health Organization: International Statistical Classification of Diseases and Related Health Problems, 10th Revision. Geneva, World Health Organization, 1992.
  9. Berrios GE, Luque R: Cotard’s syndrome: analysis of 100 cases. Acta Psychiatr Scand 1995;91:185–188.
  10. Butler PV: Diurnal variation in Cotard’s syndrome (copresent with Capgras delusion) following traumatic brain injury. Aust NZ J Psychiatry 2000;34:684–687.
  11. Winikates J, Jankovic J: Clinical correlates of vascular parkinsonism. Arch Neurol 1999;56:98–102.
  12. Thanvi B, Lo N, Robinson T: Vascular parkinsonism – an important cause of parkinsonism in older people. Age Ageing 2005;34:114–119. DOI: 10.1093/ageing/afi025.
  13. Rascol O, Brooks DJ, Korczyn AD, De Deyn PP, Clarke CE, Lang AE: A five-year study of the incidence of dyskinesia in patients with early Parkinson’s disease who were treated with ropinirole or levodopa. 056 Study Group. New Engl J Med 2000;342:1484–1491.
  14. Ecker D, Unrath A, Kassubek J, Sabolek M: Dopamine Agonists and their risk to induce psychotic episodes in Parkinson’s disease: a case-control study. BMC Neurol 2009;9:23.
  15. Westermeyer J: A case of Koro in a refugee family: association with depression and folie a deux. J Clin Psychiatry 1989;50:181–183.
  16. Bulbena A, Martín-Santos R, Mateo A, Gelabert A: Koro syndrome: first case in Spain. Medicina Clínica (Barc) 1990;94:36.
  17. Turnier L, Chouinard G: The anti-Koro effect of a tricyclic antidepressant. Can J Psychiatry 1990;35:331–333.
  18. Sajjad HA, Gill KU: Koro: a case of the genital retraction syndrome in Ireland. Ir J Psych Medicine 1993;10:40–41.

    External Resources

  19. Adeniran RA, Jones JR: Koro: culture-bound disorder or universal symptom? Br J Psychiatry 1994;164:559–561.
  20. Wolf G, McKenzie K: Capgras, Fregoli and Cotard’s syndrome and Koro in folie a deux. Br J Psychiatry 1994;165:842.
  21. Kennedy N, McDonough M: Koro: a case in an Eastern European asylum seeker in Ireland. Ir J Psych Med 2002;19:130–131.
  22. Freudenmann RW, Schönfeldt-Lecuona C: Koro-like symptoms in a recurrent depressive disorder. Nervenarzt 2005;76:885–887.
  23. Durst R, Rosca-Rebaudengo P: Koro secondary to a tumour of the corpus callosum. Br J Psychiatry 1988;153:251–254.
  24. Dantendorfer K, Amering M, Prayer D, Maierhofer D, Schnider P, Katsching H: Treatment of Koro and panic attacks after stroke. Anxiety 1996;2:53–55.
  25. Kudlur SNC, George S, Jaimon M: An overview of the neurological correlates of Cotard syndrome. Eur J Psychiat 2007;21:99–116.

    External Resources

  26. Mendhekar DN, Gupta N: Recurrent postictal depression with Cotard delusion. Indian J Pediatr 2005;72:29–31.

    External Resources

  27. Young AW, Leafhead KM, Szulecka TK: The Capgras and Cotard delusions. Psychopathology 1994;27:226–231.
  28. Vigotsky LS, Kasanin J: Thought in schizophrenia. Arch Neurol Psychiatry 1934;31:1063–1077.
  29. Iakimova G, Passerieux C, Denhière G, Laurent JP, Vistoli D, Vilain J, Hardy-Baylé MC: The influence of idiomatic salience during the comprehension of ambiguous idioms by patients with schizophrenia. Psychiatry Res 2010;177:46–54.
  30. Factor SA, Molho ES: Threatening auditory hallucinations and Cotard syndrome in Parkinson disease. Clin Neuropharmacol 2004;27:205–207.
  31. Alexopoulos GS, Meyers BS, Young RC, Kakuma T, Silbersweig D, Charlson M: Clinically defined vascular depression. Am J Psychiatry 1997;154:562–565.


Pay-per-View Options
Direct payment This item at the regular price: USD 33.00
Payment from account With a Karger Pay-per-View account (down payment USD 150) you profit from a special rate for this and other single items.
This item at the discounted price: USD 23.00